Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction
Background: As inflammation following ST-segment elevation myocardial infarction (STEMI) is both beneficial and deleterious, there is a need to find new biomarkers of STEMI severity.Objective: We hypothesized that the circulating concentration of the soluble tumor necrosis factor α receptors 1 and 2...
Main Authors: | Alexandre Paccalet, Claire Crola Da Silva, Laura Mechtouff, Camille Amaz, Yvonne Varillon, Charles de Bourguignon, Regine Cartier, Cyril Prieur, Danka Tomasevic, Nathalie Genot, Simon Leboube, François Derimay, Gilles Rioufol, Eric Bonnefoy-Cudraz, Nathan Mewton, Michel Ovize, Gabriel Bidaux, Thomas Bochaton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.656928/full |
Similar Items
-
Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients
by: Ahmad Hayek, et al.
Published: (2021-06-01) -
Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients.
by: Thomas Bochaton, et al.
Published: (2021-01-01) -
Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction.
by: Thomas Bochaton, et al.
Published: (2017-01-01) -
Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench
by: Maya Dia, et al.
Published: (2021-03-01) -
Comparison of visual scoring and planimetry methods for estimation of global infarct size on delayed contrast enhanced MRI and confrontation with biochemical markers of infarction
by: Ovize Michel, et al.
Published: (2009-01-01)